Blair William & CO Eli Lilly & CO Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Blair William & CO holds 339,298 shares of LLY stock, worth $254 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

339,298

Previous 346,588 2.1%

Holding current value

$254 Million

Previous $314 Million 4.21%

% of portfolio

0.9%

Previous 0.98%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $5.63 Million - $7 Million	-7,290 Reduced 2.1%	339,298 $301 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $11 Million - $13.8 Million	15,133 Added 4.57%	346,588 $314 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $3.49 Million - $4.66 Million	5,888 Added 1.81%	331,455 $258 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $1.52 Million - $1.79 Million	-2,885 Reduced 0.88%	325,567 $190 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $729,861 - $1.01 Million	-1,679 Reduced 0.51%	328,452 $176 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $4.43 Million - $5.92 Million	12,633 Added 3.98%	330,131 $155 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.19 Million - $1.4 Million	3,833 Added 1.22%	317,498 $109 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $2.56 Million - $2.99 Million	7,976 Added 2.61%	313,665 $115 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $3.22 Million - $3.68 Million	10,877 Added 3.69%	305,689 $98.8 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $6.18 Million - $7.26 Million	22,189 Added 8.14%	294,812 $95.6 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $733,406 - $911,437	3,125 Added 1.16%	272,623 $78.1 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $653,863 - $811,448	2,908 Added 1.09%	269,498 $74.4 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $176,393 - $217,077	-796 Reduced 0.3%	266,590 $61.6 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $3.08 Million - $3.99 Million	-17,064 Reduced 6.0%	267,386 $61.4 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $3.08 Million - $3.98 Million	-18,715 Reduced 6.17%	284,450 $53.1 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $2.28 Million - $3.02 Million	-17,507 Reduced 5.46%	303,165 $51.2 Million
Q3 2020 Nov 06, 2020	BUY	$146.22 - $169.13 $1.79 Million - $2.07 Million	12,250 Added 3.97%	320,672 $47.5 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $493,840 - $594,331	-3,620 Reduced 1.16%	308,422 $50.6 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $2.79 Million - $3.45 Million	-23,412 Reduced 6.98%	312,042 $43.3 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $5.37 Million - $6.65 Million	50,249 Added 17.62%	335,454 $44.1 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $96,004 - $104,427	899 Added 0.32%	285,205 $31.9 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $1.47 Million - $1.71 Million	13,246 Added 4.89%	284,306 $31.5 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $1.75 Million - $2.06 Million	15,733 Added 6.16%	271,060 $35.2 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.01 Million - $1.13 Million	9,526 Added 3.88%	255,327 $29.5 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $818,417 - $1.02 Million	9,532 Added 4.03%	245,801 $26.4 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $70,173 - $80,537	927 Added 0.39%	236,269 $20.2 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $16 Million - $18.9 Million	-215,565 Reduced 47.81%	235,342 $18.2 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $7.65 Million - $8.21 Million	93,368 Added 26.11%	450,907 $38.1 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $27.6 Million - $30.6 Million	357,539	357,539 $30.6 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account